You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases

Article metrics

Article menu

Download PDFPDF

Respiratory infection
Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases

 

Online download statistics by month:

Online download statistics by month: July 2022 to March 2024

AbstractFullPdf
Jul 2022374384120
Aug 202219519574
Sep 202211912026
Oct 202211712222
Nov 202210910922
Dec 2022817723
Jan 202310110123
Feb 2023888624
Mar 2023636132
Apr 2023595021
May 2023424511
Jun 202341394
Jul 2023464563
Aug 202338359
Sep 202359538
Oct 2023484714
Nov 2023626518
Dec 2023805614
Jan 202471589
Feb 2024564620
Mar 2024808211
Total19291876568